IBDEI184 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21672,0)
 ;;=453.1^^118^1343^54
 ;;^UTILITY(U,$J,358.3,21672,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21672,1,4,0)
 ;;=4^453.1
 ;;^UTILITY(U,$J,358.3,21672,1,5,0)
 ;;=5^Thrombophlebitis Migra
 ;;^UTILITY(U,$J,358.3,21672,2)
 ;;=^265511
 ;;^UTILITY(U,$J,358.3,21673,0)
 ;;=453.2^^118^1343^49
 ;;^UTILITY(U,$J,358.3,21673,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21673,1,4,0)
 ;;=4^453.2
 ;;^UTILITY(U,$J,358.3,21673,1,5,0)
 ;;=5^Thombus Vena Cava
 ;;^UTILITY(U,$J,358.3,21673,2)
 ;;=^269817
 ;;^UTILITY(U,$J,358.3,21674,0)
 ;;=453.3^^118^1343^60
 ;;^UTILITY(U,$J,358.3,21674,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21674,1,4,0)
 ;;=4^453.3
 ;;^UTILITY(U,$J,358.3,21674,1,5,0)
 ;;=5^Thrombus Renal Vein
 ;;^UTILITY(U,$J,358.3,21674,2)
 ;;=^269818
 ;;^UTILITY(U,$J,358.3,21675,0)
 ;;=459.2^^118^1343^47
 ;;^UTILITY(U,$J,358.3,21675,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21675,1,4,0)
 ;;=4^459.2
 ;;^UTILITY(U,$J,358.3,21675,1,5,0)
 ;;=5^Stricture Vein
 ;;^UTILITY(U,$J,358.3,21675,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,21676,0)
 ;;=459.81^^118^1343^39
 ;;^UTILITY(U,$J,358.3,21676,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21676,1,4,0)
 ;;=4^459.81
 ;;^UTILITY(U,$J,358.3,21676,1,5,0)
 ;;=5^Chronic Venous Insuf
 ;;^UTILITY(U,$J,358.3,21676,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,21677,0)
 ;;=451.11^^118^1343^42
 ;;^UTILITY(U,$J,358.3,21677,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21677,1,4,0)
 ;;=4^451.11
 ;;^UTILITY(U,$J,358.3,21677,1,5,0)
 ;;=5^Phleb/Throm Fem V Deep
 ;;^UTILITY(U,$J,358.3,21677,2)
 ;;=^269811
 ;;^UTILITY(U,$J,358.3,21678,0)
 ;;=438.89^^118^1343^38
 ;;^UTILITY(U,$J,358.3,21678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21678,1,4,0)
 ;;=4^438.89
 ;;^UTILITY(U,$J,358.3,21678,1,5,0)
 ;;=5^CVA, Late Effect
 ;;^UTILITY(U,$J,358.3,21678,2)
 ;;=^317924
 ;;^UTILITY(U,$J,358.3,21679,0)
 ;;=453.89^^118^1343^59
 ;;^UTILITY(U,$J,358.3,21679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21679,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,21679,1,5,0)
 ;;=5^Thrombus Other Vein
 ;;^UTILITY(U,$J,358.3,21679,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,21680,0)
 ;;=444.01^^118^1343^45
 ;;^UTILITY(U,$J,358.3,21680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21680,1,4,0)
 ;;=4^444.01
 ;;^UTILITY(U,$J,358.3,21680,1,5,0)
 ;;=5^Saddle Embolus-Abd Aorta
 ;;^UTILITY(U,$J,358.3,21680,2)
 ;;=^340522
 ;;^UTILITY(U,$J,358.3,21681,0)
 ;;=444.09^^118^1343^16
 ;;^UTILITY(U,$J,358.3,21681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21681,1,4,0)
 ;;=4^444.09
 ;;^UTILITY(U,$J,358.3,21681,1,5,0)
 ;;=5^Art Emb/Thrm Abd Aorta NEC
 ;;^UTILITY(U,$J,358.3,21681,2)
 ;;=^340523
 ;;^UTILITY(U,$J,358.3,21682,0)
 ;;=078.5^^118^1344^1
 ;;^UTILITY(U,$J,358.3,21682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21682,1,4,0)
 ;;=4^078.5
 ;;^UTILITY(U,$J,358.3,21682,1,5,0)
 ;;=5^CMV Infection
 ;;^UTILITY(U,$J,358.3,21682,2)
 ;;=^30676
 ;;^UTILITY(U,$J,358.3,21683,0)
 ;;=420.90^^118^1344^8
 ;;^UTILITY(U,$J,358.3,21683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21683,1,4,0)
 ;;=4^420.90
 ;;^UTILITY(U,$J,358.3,21683,1,5,0)
 ;;=5^Pericarditis, Acute
 ;;^UTILITY(U,$J,358.3,21683,2)
 ;;=^269692
 ;;^UTILITY(U,$J,358.3,21684,0)
 ;;=420.91^^118^1344^7
 ;;^UTILITY(U,$J,358.3,21684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21684,1,4,0)
 ;;=4^420.91
 ;;^UTILITY(U,$J,358.3,21684,1,5,0)
 ;;=5^Pericardit, Acute Viral
 ;;^UTILITY(U,$J,358.3,21684,2)
 ;;=^269695
 ;;^UTILITY(U,$J,358.3,21685,0)
 ;;=421.0^^118^1344^5
 ;;^UTILITY(U,$J,358.3,21685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21685,1,4,0)
 ;;=4^421.0
 ;;^UTILITY(U,$J,358.3,21685,1,5,0)
 ;;=5^Endocarditis, Acute/Sub Bact
 ;;
 ;;$END ROU IBDEI184
